EMEA guidelines for trials in osteoporosis: design implications
- PMID: 12481877
EMEA guidelines for trials in osteoporosis: design implications
Abstract
The design, execution and interpretation of trials that do not contain a placebo arm are a challenge. These issues are briefly discussed in the context of the new European guidelines for the study of drugs for the indication prevention and treatment of postmenopausal osteoporosis.
Comment in
-
Osteoporosis: disease, risk factor or hype?Neth J Med. 2002 Sep;60(8):307-9. Neth J Med. 2002. PMID: 12481876 No abstract available.
MeSH terms
LinkOut - more resources
Full Text Sources
